Bone Health in Adult Populations: The Synergistic Role of Calcium Carbonate & Vitamin D3 (Adcal D)

The Silent Epidemic of Osteopenia in South Asia

Osteoporosis and age-related bone mineral density (BMD) loss represent major public health concerns across Bangladesh, particularly among post-menopausal women and elderly adults. Inadequate dietary calcium intake combined with subclinical Vitamin D deficiency accelerates skeletal resorption, significantly increasing the risk of fragility fractures.

Synergistic Pharmacodynamics of Adcal D

Monotherapy with calcium alone is frequently insufficient due to limited intestinal absorption. Adcal D provides a balanced combination of 500 mg Elemental Calcium (as Calcium Carbonate BP 1250 mg) and 200 IU Cholecalciferol (Vitamin D3 BP):

• Enhanced Active Transport: Vitamin D3 is metabolized in the liver and kidneys to calcitriol, which induces calcium-binding protein (calbindin-D28k) synthesis in enterocytes, boosting calcium absorption efficiency by over 300%.
• Parathyroid Hormone (PTH) Suppression: Adequate serum calcium levels prevent secondary hyperparathyroidism, shutting down osteoclast-mediated bone breakdown.
• High Bioavailability Salt: Calcium Carbonate provides 40% elemental calcium by weight, maximizing therapeutic yield in an easily swallowable film-coated tablet.

Clinical Indications & Dosage

Adcal D is indicated for the prevention and treatment of osteoporosis, osteomalacia, rickets, and conditions requiring increased calcium supplementation during pregnancy and lactation. The standard adult regimen is one tablet once or twice daily, preferably taken with or immediately after meals to maximize acid-dependent dissolution.